2 Cases of Mumps Orchitis Treated with Systemic Interferon-alpha2.
- Author:
Jun Taik YI
1
;
Sang Don LEE
;
Moon Kee CHUNG
Author Information
1. Department of Urology, College of Medicine, Pusan National University, Pusan, Korea.
- Publication Type:Case Report
- Keywords:
Mumps orchitis;
Interferon-alpha2
- MeSH:
Atrophy;
Follow-Up Studies;
Humans;
Incidence;
Infertility;
Interferons;
Male;
Mumps*;
Orchitis*;
Testis
- From:Korean Journal of Urology
1999;40(10):1385-1392
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Mumps orchitis represents the most common complication of mumps infections and occurs in 5 to 37% of the populations. The most important danger is the risk of testicular atrophy up to 50% of affected testis which results in sterility. Two patients with mumps orchitis received systemic treatment with Interferon-alpha2(INF-alpha2)(3x06IU per day) for 7 days. All acute symptoms and signs of mumps orchitis disappeared within 4-7 days of INF-alpha2 therapy. No incidence of testicular atrophy was observed at the 19 and 6 months follow-up, respectively. No significant adverse effects of drug were occurred during treatment. We recommend the immediate interferon therapy, as soon as mumps orchitis manifests, to relieve clinical manifestation and to prevent testicualr atrophy and resulting infertility.
